39 46

Cited 0 times in

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation

DC FieldValueLanguage
dc.contributor.author유희태-
dc.contributor.author엄재선-
dc.contributor.author박제욱-
dc.contributor.author박희남-
dc.contributor.author이문형-
dc.contributor.author김태훈-
dc.contributor.author정보영-
dc.contributor.author김민-
dc.date.accessioned2020-09-29T00:43:48Z-
dc.date.available2020-09-29T00:43:48Z-
dc.date.issued2020-06-
dc.identifier.issn1738-5520-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179382-
dc.description.abstractBackground and objectives: Little is known about the outcomes of outpatient clinic-based elective external cardioversion (OPC-ECV) for persistent atrial fibrillation (PeAF). We investigated the acute, short-term, and long-term elective external cardioversion (ECV) outcomes. Methods: We included 1,718 patients who underwent OPC-ECV (74% male, 61.1±11.0 years old, 90.9% long-standing PeAF, 9.1% after atrial fibrillation [AF] ablation) after excluding patients with atrial tachycardia or inappropriate antiarrhythmic drug medication, and in-patient ECV. Biphasic shocks were delivered sequentially until successful cardioversion was achieved (70-100-150-200-250 J). If ECV failed at 150 J, we administered intravenous amiodarone 150 mg and delivered 200 J. Results: ECV failed in 11.4%, and the complication rate was 0.47%. Within 3 months, AF recurred in 55.5% (44.7% as sustaining AF, 10.8% as paroxysmal AF), and the AF duration was independently associated (odds ratio [OR], 1.01 [1.00-1.02]; p=0.006), but amiodarone was independently protective (OR, 0.46 [0.27-0.76]; p=0.002, Log rank p<0.001) against an early recurrence. Regarding the long-term recurrence, pre-ECV heart failure was protective against an AF recurrence (hazard ratio, 0.63 [0.41-0.96], p=0.033) over 32 (9-66) months of follow-up. ECV energy (p<0.001) and early recurrence rate within 3 months (p=0.007, Log rank p=0.006) were significantly lower in post-ablation patients than in those with long-standing persistent AF. Conclusions: The success rate of OPC-ECV was 88.6%, and the complication rate was low. However, AF recurred in 55.5% within 3 months. Amiodarone was protective against short-term AF recurrences, and long-term AF recurrences were less in patients with baseline heart failure.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish, Korean-
dc.publisherKorean Society of Circulation-
dc.relation.isPartOfKOREAN CIRCULATION JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEfficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorNguyen Khac Le Son-
dc.contributor.googleauthorJe Wook Park-
dc.contributor.googleauthorMin Kim-
dc.contributor.googleauthorSong Yi Yang-
dc.contributor.googleauthorHee Tae Yu-
dc.contributor.googleauthorTae Hoon Kim-
dc.contributor.googleauthorJae Sun Uhm-
dc.contributor.googleauthorBoyoung Joung-
dc.contributor.googleauthorMoon Hyoung Lee-
dc.contributor.googleauthorHui Nam Pak-
dc.identifier.doi10.4070/kcj.2019.0310-
dc.contributor.localIdA02535-
dc.contributor.localIdA02337-
dc.contributor.localIdA02337-
dc.contributor.localIdA04574-
dc.contributor.localIdA04574-
dc.contributor.localIdA01776-
dc.contributor.localIdA01776-
dc.contributor.localIdA02766-
dc.contributor.localIdA02766-
dc.contributor.localIdA01085-
dc.contributor.localIdA01085-
dc.contributor.localIdA03609-
dc.contributor.localIdA03609-
dc.relation.journalcodeJ01952-
dc.identifier.eissn1738-5555-
dc.identifier.pmid32212425-
dc.subject.keywordAtrial fibrillation-
dc.subject.keywordCardioversion-
dc.subject.keywordRecurrence-
dc.contributor.alternativeNameYu, Hee Tae-
dc.contributor.affiliatedAuthor유희태-
dc.contributor.affiliatedAuthor엄재선-
dc.contributor.affiliatedAuthor엄재선-
dc.contributor.affiliatedAuthor박제욱-
dc.contributor.affiliatedAuthor박제욱-
dc.contributor.affiliatedAuthor박희남-
dc.contributor.affiliatedAuthor박희남-
dc.contributor.affiliatedAuthor이문형-
dc.contributor.affiliatedAuthor이문형-
dc.contributor.affiliatedAuthor김태훈-
dc.contributor.affiliatedAuthor김태훈-
dc.contributor.affiliatedAuthor정보영-
dc.contributor.affiliatedAuthor정보영-
dc.citation.volume50-
dc.citation.number6-
dc.citation.startPage511-
dc.citation.endPage523-
dc.identifier.bibliographicCitationKOREAN CIRCULATION JOURNAL, Vol.50(6) : 511-523, 2020-06-
dc.identifier.rimsid67322-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.